foxo4 dri peptide senolytic 2024 inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis FOXO4 D-Retro-Inverso(DRI) peptide
Description
shipping is available on qualifying orders
Convenient 10mL multi-dose vial
At Spectrum Healthcare, we aim to empower our patients with clear, balanced, evidence based information so they can make informed decisions in partnership with their treating practitioner.
Download our peptide solubilization protocol for free.
